|
Volumn 22, Issue 2, 2009, Pages 175-179
|
Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system
|
Author keywords
In situ gelling; Ofloxacin; Ophthalmic delivery systems; Sodium alginate; Sustained
|
Indexed keywords
ALGINIC ACID;
BENZALKONIUM CHLORIDE;
EYE DROPS;
HYDROXYPROPYLCELLULOSE;
OFLOXACIN;
ANTIINFECTIVE AGENT;
CELLULOSE;
DRUG CARRIER;
DRUG DERIVATIVE;
GLUCURONIC ACID;
HEXURONIC ACID;
ANIMAL EXPERIMENT;
ARTICLE;
DRUG DELIVERY SYSTEM;
GEL;
GELATION;
IN VITRO STUDY;
MALE;
NONHUMAN;
PHASE TRANSITION;
RABBIT;
SUSTAINED RELEASE FORMULATION;
ANIMAL;
CHEMISTRY;
DELAYED RELEASE FORMULATION;
DRUG FORMULATION;
EVALUATION;
EYE;
KINETICS;
METABOLISM;
SOLUBILITY;
TOPICAL DRUG ADMINISTRATION;
VISCOSITY;
ADMINISTRATION, TOPICAL;
ALGINATES;
ANIMALS;
ANTI-BACTERIAL AGENTS;
CELLULOSE;
CHEMISTRY, PHARMACEUTICAL;
DELAYED-ACTION PREPARATIONS;
DRUG CARRIERS;
DRUG COMPOUNDING;
EYE;
GELS;
GLUCURONIC ACID;
HEXURONIC ACIDS;
KINETICS;
MALE;
OFLOXACIN;
OPHTHALMIC SOLUTIONS;
RABBITS;
SOLUBILITY;
VISCOSITY;
|
EID: 65449137096
PISSN: 1011601X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (46)
|
References (12)
|